The participants to be covered in this review will be: policy-makers, implementers, service providers, patients and beneficiaries of successful implementation of medicines pricing policies (of any gender, age, ethnicity, socioeconomic group, health status or urban–rural residence).
Copyright and License information: ©2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.